Biogen Switzerland’s Dr med Katharina Gasser outlines how her affiliate navigated the COVID-19 pandemic from an organisational and communication perspective, the increasing importance being given to mental health by the Swiss government, and the reimbursement and market challenges facing Biogen in 2021 and beyond.
2020 saw a lot of innovation, new thinking, and new approaches being developed. Change came fast, but our team did a fantastic job in first embracing the challenge and now helping to shape how interactions will look in the future
